Escherichia coli K1 is a leading pathogen in neonatal sepsis and meningitis. The K1 capsule, composed of α2,8-linked polysialic acid, represents the major virulence factor. In some K1 strains, phase-variable O-acetylation of the capsular polysaccharide is observed, a modification which is catalyzed by the prophage-encoded O-acetyltransferase NeuO. Phase variation is mediated by changes in the number of heptanucleotide repeats within the 5'-coding region of neuO and full-length translation is restricted to repeat numbers that are a multiple of three. To understand the biochemical basis of K1 capsule O-acetylation, NeuO encoded by alleles containing 0, 12, 24, and 36 repeats were expressed and purified to homogeneity via a Cterminal hexa-histidine-tag. All NeuO variants assembled into hexamers and were enzymatically active with a high substrate specificity towards polysialic acid with >14 residues. Remarkably, the catalytic efficiency (k cat /K m donor ) increased linearly with increasing numbers of repeats, revealing a new mechanism for modulating NeuO activity. Using homology modeling, we predicted a 3D-structure primarily composed of a left-handed parallel β-helix with one protruding loop. Two amino acids critical for catalytic activity were identified and corresponding alanine substitutions, H119A and W143A, resulted in a complete loss of activity without affecting the oligomerization state. Our results indicate that in NeuO typical features of an acetyltransferase of the left-handed β-helix family are combined with a unique regulatory mechanism based on variable N-terminal protein extensions formed by tandem copies of an RLKTQDS heptad.
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Escherichia coli K1 (E. coli K1)
2 is one of the main organisms causing bacterial sepsis and meningitis during the neonatal period (1) (2) (3) . The pathogenesis of E. coli meningitis is a complex process involving colonization of the gastrointestinal tract, intestinal translocation, bacteraemia, passage of the blood-brain barrier, and invasion of the arachnoidal space (4) . Cell culture experiments indicated that transfer across the blood-brain barrier is mediated by transcytosis through brain endothelial cells (5, 6) and that in contrast to other bacterial agents causing meningitis, E. coli K1 invades meningioma cells directly, leading to rapid cell death before an inflammatory response can be induced (7) . Despite advances in diagnostics and therapeutics of neonatal infections, E. coli neonatal meningitis is still characterized by high rates of mortality and a high incidence of permanent neurological sequelae in those that survive (8, 9) .
E. coli K1 is protected by a thick layer of capsular polysaccharide, which is the major virulence factor important for serum resistance and vital passage of the blood brain barrier (5, 10, 11) . The K1 capsule consists of polysialic acid (polySia) formed by the most prevalent sialic acid of humans, 5-N-acetyl neuraminic acid (Neu5Ac). Up to 200 residues are joint in α2,8-glycosidic linkages, resulting in a linear homopolymer that is structurally identical to polySia of the host organism (12, 13) . Due to this antigenic mimicry, the K1 capsule is poorly immunogenic and no effective polysaccharide based vaccines are available.
In several K1 strains, modification of the capsule by O-acetylation of the Neu5Ac residues in positions O-7 and O-9 was observed (14) (15) (16) . This modification is phase-variable and individual strains can switch between O-acetylated (OAc + ) and non-O-acetylated (OAc -) capsule variants (14) . Although associated with increased immunogenicity, modification of the K1 capsule by O-acetylation correlated with increased virulence in patients with bacteraemia (17) . Because O-acetylated polySia resists hydrolysis by neuraminidases, capsule O-acetylation may favour colonization of the intestinal tract (14) .
O-acetylation of the K1 capsule is catalyzed by an acetyl-coenzyme A (acetyl-CoA) dependent Oacetyltransferase with preferential acceptor specificity towards polysialic acid with more than 14 residues (15) . The corresponding gene (neuO) is part of a 40 kb prophage of the P22 family and phase-variation is mediated by changes in the overall length of variable number of tandem repeats (VNTRs) within the 5'-coding region (16, 18) . VNTR loci are among the most variable regions of many bacterial genomes and arise through slippage and mispairing during DNA replication due to occasional DNA polymerase dissociation (19, 20) . In the neuO positive K1 strains reported so far, 14 to 39 copies of the heptanucleotide unit 5'-AAGACTC-3' were inserted 2 nucleotides downstream of the start codon (16) . Only repeat numbers that are a multiple of 3 allow full-length translation of neuO (phase on), whereas other numbers move the start codon out of frame resulting in truncated and thereby inactive translation products (phase off). In the case of full-length translation, the presence of VNTRs will lead to significant N-terminal protein extensions with every 3 tandem heptanucleotides encoding an RLKTQDS heptad. Comparison of 10 different OAc + K1 strains indicated that VNTR-encoded protein extensions may affect NeuO activity (16) . However, direct analysis of the enzymatic activity in bacterial lysates is hampered by the high frequency of phase variation and so far, isolation of endogenous NeuO failed (15) . In the present study, we succeeded in purification of active recombinant enzyme, forming the basis for a detailed biochemical characterization of NeuO. Functional and structural analyses of variants encoded by neuO alleles with 0, 12, 24, and 36 heptanucleotide repeats revealed that NeuO shares the typical features of an acyltransferase of the left-handed-β-helix (LβH) superfamily and assembles into hexamers which might be formed by dimerization of two trimers. In contrast to other members of the LβH family, NeuO activity is regulated by changes in the number of N-terminal RLKTQDS heptads and the catalytic efficiency gradually increases with the length of this VNTR-encoded protein extension.
EXPERIMENTAL PROCEDURES
Materials. E. coli K1 strains A160 and C375 were kindly provided by M. Achtman and F. Ørskov, respectively. pET expression vectors and E. coli BL21(DE3) were obtained from Novagen. CMP-Neu5Ac, Neu5Ac, colominic acid, 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB, Ellman's reagent), acetyl-, propionyl-, and buturyl-CoA were purchased from Sigma. Isolated sialic acid dimers, trimers, tetramers, pentamers and hexamers were obtained from Nacalai-Tesque.
Cloning of the capsule specific Oacetyltransferase of E. coli K1. In parallel to Deszo et -affinity chromatography using HisTrap-chelating HP columns (GE Healthcare). Bacteria were resuspended in binding buffer (20 mM Tris-HCl pH 8.0/ 500 mM NaCl/ 40 mM imidazole), lysed by sonication and the soluble fraction was applied to a 1 ml column according to the manufacturer's instructions. After washing with 25 ml of binding buffer, proteins were eluted with a linear imidazole gradient of 40 to 500 mM imidazole in binding buffer). Imidazole was removed by gelfiltration using a HiPrep 26/10 desalting column (GE Healthcare) equilibrated with 100 mM Tris-HCl pH 8.0/ 150 mM NaCl.
In vitro assay for the determination of NeuOactivity. NeuO activity was determined in a spectrophotometric assay according to Alpers et al. (22) . In a total volume of 100 µl, the standard reaction mixture contained 20 mM Tris-HCl pH 7.5, 25 mM EDTA, 4 mM DTNB, 2 mg/ml colominic acid, and 1 mM acetyl-CoA and the reaction was initiated by adding 24 pmoles of purified enzyme. The reaction was performed at 25°C and monitored continuously at 405 nm in half-area 96-well plates (Greiner) using a PowerWave 340 microplate spectrophotometer (BioTek). For comparison of NeuO activity towards colominic acid, CMP-Neu5Ac, Neu5Ac, and Neu5Ac oligomers of different length the concentration of all acceptor substrates were normalized to equal sialic acid content (6.85 mM) and thereby to an equal number of acceptor sites. For quantification of the sialic acid content, oligomers were hydrolyzed to free sialic acid by treatment with 100 mM TFA for 4 h at 80°C followed by the thiobarbituric acid assay according to Skoza and Mohos (23) using Neu5Ac as standard.
Kinetic analysis. The acceptor and donor kinetics were carried out on purified NeuO variants using the spectrophotometric assay described above. The steady-state parameters, K m and k cat , were determined by holding one substrate at saturating concentration while the concentration of the second substrate was varied. Twelve different concentrations of donor (0.025-2 mM acetyl-CoA) and acceptor substrate (2-215 µM colominic acid) were used. Kinetic parameters were obtained by fitting the initial rate data to the Michaelis-Menten equation using nonlinear regression analysis with Prism 4.0 software (GraphPad Software, Inc.).
Analysis of NeuO acitivity in vivo. NeuO lacking the VNTR-region was amplified by PCR using the primers HC412 (5'-GCGCGCGGATCCCGTTTTCCGTTGATGATA ATGGG-3') and HC406 (5'-GCGCGCCTGCAGTATTTATTGCGTGAGCTT CGC-3') containing BamHI and PstI sites (underlined), respectively. The above described pET-based plasmids containing neuO encoding either wild-type or mutated variants with the amino acid exchanges H119A and W143A were used as a template. PCR products were ligated into BamHI/PstI sites of pQE32 (Qiagen) and the identity of all constructs was confirmed by DNAsequencing. The resulting plasmids were transformed into E. coli K1 strain A160, which lacks endogenous neuO. Bacteria were grown on LB-agar containing 100 µg/ml ampicillin and 20 µl of a bacterial suspension (optical density at 600 nm = 0.1) were added to each well of a microtiter plate (Greiner) coated with poly-Dlysine (Sigma). After drying, bacteria were fixed with 0.05% glutaraldehyde in phosphate-buffer saline (PBS). Capsule expression and modification by O-acetylation was monitored in an enzymelinked immunosorbent assay (ELISA) as described previously (24) The reaction mixture was separated by high percentage PAGE and the degree of polymerization of the smallest radioactively labeled acceptor molecule was determined by autoradiography. For generation of a radioactively labeled oligosialic acid marker ladder, the solidphase fixed polysialyltransferase ST8SiaIV/PST-1 was autopolysialylated in vitro in the presence of CMP-[ 14 C]Neu5Ac (GE Healthcare) as described (26) . After removal of unbound substrate, radioactively labeled sialic acid oligomers were released by partial endosialidase cleavage.
Analysis of polysialic acid by high percentage PAGE. Sialic acid oligo-and polymers were separated on 25% polyacrylamide gels as described (27) . Electrophoresis was performed for 4 h at 4°C and 400 V, using 14 cm gels (0.8 mm thick).
Immediately after electrophoresis, acrylamide gels were vacuum-dried and exposed to Hyperfilm-MP (GE Healthcare).
SDS-PAGE, silver staining, and immunoblotting. SDS-PAGE was performed under reducing conditions using 2.5% (v/v) β-mercaptoethanol. Silver staining and Western blot analysis were performed as described previously (28) . For detection of hexa-histidine-tag penta-His antibody (Qiagen) was used at a concentration of 1 µg/ml. Strep-tagged proteins were detected with StrepTactin-AP conjugate (IBA) at a 1:4000 dilution.
Size-exclusion chromatography. The quaternary structure of wild-type and mutant NeuO was determined on a Superdex 200 HR 10/30 column (GE Healthcare). The column was equilibrated with 100 mM Tris-HCl pH 8.0/ 150 mM NaCl and calibrated with molecular weight standards (Sigma) thyroglobulin (669 kDa), β-amylase (200 kDa), alcohol dehydrogenase (150 kDa), bovine serum albumin (66 kDa), carbonic anhydrase (29 kDa), and cytochrome C (12.4 kDa). 1 mg of affinity purified wild-type or mutant NeuO was applied to the column and eluted protein was monitored by absorbance at 280 nm. (16) . As shown in Fig. 1A , full-length translation and thereby expression of active NeuO depends on repeat numbers that are dividable by three. In the case of full-length translation, every three tandem heptanucleotides encode an RLKTQDS heptad.
RESULTS

Purification of NeuO variants with variable N-terminal protein extensions
To investigate the role of N-terminal heptads on protein expression and activity, a set of neuO alleles with 0, 12, 24, and 36 heptanucleotide repeats was generated and the corresponding translation products were termed NeuO+0, NeuO+12, NeuO+24, and NeuO+36, respectively. Each variant was expressed in E. coli BL21(DE3) with an N-terminal Strep-and a C-terminal hexahistidine-tag (see Fig. 1B for schematic representation). Recombinant proteins were isolated by immobilized metal affinity chromatography (IMAC) using the C-terminal hexa-histidine-tag. Notably, high imidazole concentrations (≥450 mM) were required for the elution of all variants, indicating tight adsorption to the IMAC matrix. Because NeuO was unstable under these conditions, fractions eluted from the IMAC column were loaded immediately onto a Sephadex G25 column to remove imidazole. Using this purification protocol, all NeuO variants were purified to homogeneity (Fig. 1C and D) . Silver staining revealed single bands with an apparent molecular mass consistent with the calculated mass of the respective variant (Fig.  1B,D) . Western blot analysis using StrepTactin and anti-penta-His antibody (Fig. 1D , middle and right panel) revealed that neuO alleles with 12, 24, and 36 heptanucleotide units were translated in full-length proteins with the expected N-terminal extensions of 28, 56, and 84 amino acids, respectively, and no proteolytic cleavage or degradation of the heptad region was observed. From 1-liter cultures, 2.5 mg of purified NeuO+0 was obtained (Fig. 1B) . Expression levels and protein yields increased with increasing numbers of VNTRs, suggesting that heptads contribute to protein stability. Since the insertion of 12, 24, and 36 nucleotide repeats increases the molecular mass of the translation products by 13, 25, and 37%, respectively, protein yields were compared on the molar level revealing a 2-fold higher protein yield for NeuO+36 than for NeuO+0 (Fig. 1B) .
It is worth noting that none of the NeuO variants bound significantly to a StrepTactin column, although the N-terminal Strep-tag was detectable by Western blotting (Fig. 1D, middle  panel) . This observation indicates that in native NeuO the N-terminus is not accessible. Remarkably, this finding was irrespective of the presence or absence of heptad repeats (data not shown). For the unequivocal detection of fulllength proteins, we kept the Strep-tag in all used constructs. Direct comparison of NeuO with and without Strep-tag revealed that this tag did not affect NeuO activity (data not shown).
N-terminal heptads are dispensable for enzymatic activity of isolated NeuO − After demonstrating that heptanucleotide repeats are translated in stable protein extensions, we asked whether RLKTQDS heptads are essential for enzymatic activity of NeuO. To investigate this point, the O-acetyltransferase activity of NeuO variants with and without heptad repeats was determined in a modified Alpers assay (22) . In this spectrophotometric assay, the transfer of acetyl groups from acetyl-CoA to polysialic acid is followed by measuring the appearance of the free sulfhydryl group of CoA-SH with Ellman's reagent. Reactions were initiated by adding equimolar amounts of purified NeuO+0, NeuO+12, NeuO+24, or NeuO+36 and the optical density was monitored at 405 nm. Under the applied conditions of high donor and acceptor substrate concentrations, NeuO+0 and NeuO+12 showed comparable enzymatic activities (Fig. 1E) , demonstrating that N-terminal RLKTQDS heptads are dispensable for enzymatic activity. Interestingly, increased activities were observed for NeuO+24 and NeuO+36, indicating that VNTR-encoded protein extensions influence the enzymatic properties of NeuO.
RLKTQDS heptad repeats increase the catalytic efficiency of NeuO − To further investigate the effect of heptad repeats on the activity of NeuO, substrate kinetics of purified NeuO variants with and without RLKTQDS repeats were compared. In a first step, steady-state kinetic constants of NeuO+0, NeuO+12, NeuO+24, and NeuO+36 were determined for the donor substrate using 12 different concentrations of acetyl-CoA. All kinetic analyses were performed at 25°C and yielded linear LineweaverBurk plots (see Fig. S1 and S2 in the Supplementary Material). The donor K m value of NeuO+0 was determined to be 0.4 mM ( Fig. 2A) . These results suggest that the presence of heptad repeats result in gradual changes in enzyme conformation allowing an increase in enzyme-donor substrate affinity and facilitation of the reaction rate.
In a second step, kinetic parameters for the acceptor were determined using 12 different polysialic acid concentrations. As an acceptor substrate, we used colominic acid, a commercially available mixture of oligomeric α2,8-linked sialic acid. Analysis of the batch used in the present study revealed oligomer lengths ranging from 2 to over 60 residues and an average degree of polymerization (DP) of 32. To acknowledge the fact that colominic acid is heterogeneous in polymer length, and that longer polymers contain more acceptor sites than shorter chains, acceptor concentrations were expressed as concentration of total sialic acids. Since acceptor affinities may vary with polySia chain length and also between internal and terminal sialic acids residues, acceptor K m values will represent average values. For NeuO+0, the acceptor K m value was determined to be 1.17 mM (Table 1) . In contrast to the donor K m values, no significant differences in K m acceptor were observed for NeuO variants with and without heptad repeats. Therefore, the k cat /K m acceptor value was only 2-fold higher for NeuO+36 compared to NeuO+0 (Table 1 ) and the catalytic efficiency also increased with the number of repeats (Fig. 2B) .
Donor specificity of NeuO − In addition to acetyl-CoA, the alternative acyl donors propionylCoA and buturyl-CoA were assayed as substrates for NeuO. Buturyl-CoA turned out to be a very poor substrate and even at a concentration of 1 mM, no transfer activity was observed. PropionylCoA, however, was used as a donor substrate. Similar to the results obtained with acetyl-CoA, increased enzymatic activities were monitored for NeuO+36 compared to NeuO+0 (data not shown). Kinetic parameters were evaluated only for NeuO+36 and results are summarized in Table 1  (bottom row) .
Interestingly, identical K m values were obtained for acetyl-and propionyl-CoA, indicating that the binding pocket for the donor substrate can accommodate the larger acyl-chain of propionylCoA. However, a 13-fold decrease in k cat was observed for propionyl-CoA, indicating that the free energy for the transition state of the rate limiting step is significantly higher for propionylCoA compared to acetyl-CoA.
Acceptor specificity of NeuO − To investigate the acceptor substrate specificity of NeuO, the enzymatic activity of purified enzyme was monitored in the presence of sialic acid monomers (Neu5Ac), activated sialic acid (CMP-Neu5Ac), and a set of short α2,8-linked sialic acid oligomers with defined DPs in the range of dimer to hexamer. Since different kinetic properties were observed for NeuO variants with and without heptad repeats, acceptor substrate specificities were analyzed in parallel for NeuO+0 and NeuO+36. In contrast to colominic acid, none of the assayed compounds was used as an acceptor (Table 2) . This result demonstrates, that NeuO is highly specific for polySia and that even an α2,8-linked sialic acid hexamer is too short for NeuOcatalyzed O-acetylation.
To determine the minimal acceptor length of NeuO, we performed a radioactive incorporation assay. Purified NeuO+0 and NeuO+36 were incubated in the presence of 14 C-labeled acetylCoA and colominic acid as acceptor substrate. After separation by high percentage PAGE, reaction products were visualized by autoradiography. Because only those oligomers modified by O-acetylation will become radioactively labeled, the length of the shortest visible oligomer will represent the minimal acceptor length required. As a size marker, 14 Clabeled polySia was partially digested with endosialidase, resulting in an oligomer ladder starting with DP 3 (26) . For the two enzyme variants, NeuO+0 and NeuO+36, reaction products of similar length were obtained and results are shown exemplarily for NeuO+36 (Fig. 3) . Faint radioactive signals became visible for oligomers with DP 14-16 and strong signals were obtained for oligomers >16 residues. Together, these results demonstrate high acceptor substrate specificity of NeuO for sialic acid oligomers >14 residues.
Homology modeling of the catalytic part of NeuO − Primary sequence analysis of NeuO revealed similarity to the hexapeptide repeat family of acyltransferases (16, 29) . Proteins of this family are characterized by tandem repeats of a hexapeptide with the consensus motif [LIV]-[GAED]-X 2 -[STAV]-X which forms alternating short beta-strands and tight turns resulting in a triangular left-handed beta-helix (LβH) (30) . All members of the hexapeptide acyltransferase superfamily assemble into catalytic trimers with three symmetrically arranged catalytic sites at the interface between the monomers.
To gain first insight into the structure of a polysialic acid modifying O-acetyltransferase, homology models of NeuO lacking heptad repeats were generated using the program 3D-PSSM (21) . The best structural match with an E-value of 2.2×10 -4 (≥95% certainty) was obtained with the crystal structure of the maltose O-acetyltransferase (MAT) of E. coli (Protein Data Bank number 1ocx) (31) (see Fig. S3 in the Supplementary Material). The obtained model consists primarily of an LβH fold with 5⅓ triangular coils (Fig. 4) . The LβH domain covers the central and Cterminal part of NeuO (aa 61-216) and is interrupted by a single loop formed by residues 116-133 (Fig. 4C) . For the first 60 amino acids of NeuO, however, only poor predictions were obtained, indicating structural differences between the N-terminal parts of NeuO and MAT. The LβH domain of MAT is N-terminally capped by three α-helices (residues 1-55), whereas only one α-helix was predicted for NeuO.
Notably, two amino acids that are part of the active site of MAT were highly conserved in NeuO. His-113, which corresponds to His-119 in NeuO, is located in the loop that protrudes between β-sheets four and five. This residue is proposed to abstract the proton from the hydroxyl group of the acceptor prior to acetyl transfer (31,32). Trp-137, which corresponds to Trp-143 in NeuO, is located in a β-sheet of the LβH domain and is involved in binding of acetyl-CoA (31, 32) . In the homo-trimer, the tryptophane of one subunit is located opposite to the catalytic histidine of the next subunit (Fig. 4B) . In the predicted NeuO model, His-119 and Trp-143 are located at equivalent positions, suggesting similar functions in enzymatic catalysis.
Identification of catalytic residues − To prove whether His-119 and Trp-143 are crucial for enzymatic activity of NeuO, single alanine substitutions were performed. For both mutations, H119A and W143A, variants with and without 36 heptanucleotide repeats were generated and the resulting proteins were expressed in E. coli BL21(DE3) with N-terminal Strep-and C-terminal hexa-histidine tags. For either variant, similar expression levels than for the corresponding wildtype proteins were observed (data not shown), indicating that the introduced amino acid exchanges did not affect the stability of NeuO. The four mutant variants were purified to homogeneity (Fig. 5A ) and assayed for enzymatic activity. However, in contrast to the wild-type forms of NeuO+0 and NeuO+36, no enzymatic activity was detected for the corresponding mutant forms (Fig. 5B) . In addition to the in vitro analysis, the activity of NeuO variants was studied in vivo. To circumvent phase-variation, the in vivo approach was restricted to variants lacking the VNTR-region. Corresponding wild-type and mutant forms were cloned into the expression vector pQE32 and the resulting plasmids were transformed into E. coli K1 strain A160. As shown by PCR analysis, this strain lacks endogenous neuO (data not shown). Consequently, the expressed K1 capsule is OAc-negative as confirmed by an ELISA using two capsulespecific antibodies: (i) mAb 735 (25) which binds to α2,8-linked polySia irrespective of the presence or absence of O-acetylation and (ii) mAb 58-5 which recognizes exclusively the O-acetylated form of the K1 antigen (Fig. 5C) . O-acetylation of the K1 capsule of strain A160 was only observed after expression of wild-type NeuO. By contrast, no capsule O-acetylation was detected after expression of NeuO-H119A and NeuO-W143A, although K1 expression per se was not affected (Fig. 5C) . Together, these results demonstrate that His-119 and Trp-143 are essential for NeuO activity in vitro and in vivo.
NeuO assembles into hexamers − The quaternary structure of all known hexapeptide acyltranserases is trimeric with the exception of the serine acetyltransferase (SAT) of E. coli and Haemophilus influenzae, which adopts a hexameric structure that is formed by dimers of trimers (33) (34) (35) . Since trimerization is prerequisite for activity of hexapeptide acyltransferases, we asked whether the introduced mutations H119A and W143A induced conformational changes that prevent oligomerization and thereby abolished enzymatic activity of NeuO. Therefore, the quaternary structure of wild-type and mutant NeuO was determined by size exclusion chromatography and results are shown exemplarily for variants based on neuO alleles with 36 heptanucleotide repeats (Fig. 6) . For wildtype NeuO+36, a molecular mass of 217 kDa was determined corresponding to an oligomeric state of 5.9. Although the shape of NeuO is not yet known, this result indicates that NeuO is another example of a hexapeptide acyltransferase that assembles into hexamers. Similar to the structure of SAT, NeuO hexamers might be formed by dimers of trimers. Notably, both mutants, H119A and W143A, showed an identical oligomeric state, demonstrating that the introduced amino acid exchanges did not interfere with complex assembly. In summary, our data indicate that alanine substitution of His-119 and Trp-143 did not result in substantial alterations in the overall structure of NeuO. However, exchange of either residue completely abolished activity, suggesting that both amino acids are part of the active site.
DISCUSSION
Surface sialic acids are a common component and virulence factor of a variety of pathogenic bacteria (36) . In many cases, modification by O-acetylation has been observed and might play an important role in immunogenicity and survival in the host organism (14, (37) (38) (39) (40) (41) (42) . In the present study, we succeeded for the first time in purification and characterization of a polySia specific O-acetyltransferase. NeuO, which is essential for O-acetylation of the capsular polysaccharide of E. coli K1, was purified to homogeneity using a C-terminal hexa-histidine tag. Previous attempts to purify endogenous NeuO required detergent extraction and after partial purification on DEAE-sepharose, further isolation steps abolished activity (15) . By contrast, recombinant NeuO was obtained from the soluble protein fraction and the isolated enzyme was enzymatically active as demonstrated in a spectrophotometric assay and by incorporation of radioactively labeled acetyl groups into polySia. A possible explanation for the different outcome during purification of endogenous and recombinant NeuO is that in E. coli K1, efficient O-acetylation of the capsular polysaccharide might depend on tight association of NeuO with the polySia biosynthesis and transport machinery. In this case, detergent might be required to dissociate NeuO from the membrane bound protein complex, a step which can be omitted if NeuO is expressed in an E. coli strain lacking the K1 capsular polysaccharide gene complex.
The idea that in vivo NeuO-dependent O-acetylation occurs exclusively during or after polymerization of the polysaccharide but not on polySia building blocks is supported by our finding that in vitro neither Neu5Ac nor CMPNeu5Ac served as acceptor substrates for NeuO. In line with the initial observation made by Higa and Varki (15), purified NeuO was highly specific for sialic acid oligomers with more than 14 residues and efficient O-acetylation seemed to depend on oligomers with DP >16. However, to understand the structural basis of the acceptor specificity, further studies including detailed product analyses and characterization of the protein-carbohydrate interactions are required.
Using homology modeling followed by mutational analysis, we characterized NeuO as a typical member of the superfamily of hexapeptide acyltransferases. Enzymes of this family use phosphopantothenyl-based cofactors to transfer acetyl, succinyl, or long chain fatty acyl groups to free hydroxyl or amino groups of a variety of acceptor substrates. All family members contain tandem repeated imperfect copies of a hexapeptide repeat sequence with the consensus motif (29, 30) . Several members of the family have been crystallized and the solved structures revealed that this characteristic hexapeptide repeat sequence encodes folding of a left-handed parallel β-helix domain (31, (43) (44) (45) (46) (47) (48) (49) (50) . In all known cases, hexapeptide acyltransferases assemble into catalytic trimers with three symmetrical active sites which are located at the interfaces of two subunits formed by a loop protruding out of one LβH domain embracing the LβH domain of the neighboring monomer. Based on the structural characteristics, the hexapeptide repeat family is also called LβH family and includes not only acyltransferases but also a Zndependent γ-carbonic anhydrase (51).
The homology modeling performed in the present study, indicated close structural similarity of NeuO to the maltose O-acetyltransferase (MAT) (31) which is closely related to the lacA encoded galactoside O-acetyltransferase (GAT) of E. coli (45) . Similar to MAT and GAT, the predicted model of NeuO contains a short LβH domain with 5⅓ triangular coils and one protruding loop. Two amino acid residues which are critical for activity of MAT and GAT were found in equivalent positions in the NeuO model: His-119 located in the protruding loop and Trp-143 located within a β-sheet of the LβH domain. Subsequent single alanine substitutions completely abolished NeuO activity in vitro and in vivo, indicating important roles in catalysis. All acyltransferases of the LβH family crystallized so far, posses a catalytic histidine located in a loop embracing the adjacent subunit. The predicted role of this residue is to abstract a proton from the acceptor hydroxyl group, facilitating the attack of the resulting carbonyl by the acyl-donor (32, 52) . The second critical amino acid identified in the model of NeuO, Trp-143, is conserved only in a subset of acetyltransferases including MAT, GAT, xenobiotic acetyltransferases, and the Rhizobium leguminosarum nodulation factor NodL (31, 32, 44, 53) . In GAT, replacement of the corresponding Trp-139 by phenylalanine abolished the intrinsic fluorescence quench observed on acetyl-CoA binding (32) and the crystal structure of the binary complex of GAT with acetyl-CoA revealed a direct contact between the indole side chain of Trp-139 and the phosphopantothenyl arm of the co-factor (45) . In addition to donor binding, Trp-139 may serve to position the catalytic histidine relative to the hydroxyl group of the acceptor and alter its pK a (45) . In line with this dual role in donor binding and positioning of the catalytic histidine, a complete loss of NeuO activity was observed when Trp-143 was substituted by alanine. Together, these results provided convincing evidence that NeuO consists primarily of an LβH fold with His-119 and Trp-143 as part of the active site.
Using size exclusion chromatography, we demonstrated that NeuO assembles into hexamers. So far, the only example of an LβH-acyltransferase with a quaternary structure other than trimeric is the serine acetyltransferase (SAT) (54) . Similar to NeuO, SAT of E. coli and Haemophilus influenzae adopts a hexameric structure and the solved crystal structures revealed that two SAT trimers assemble into hexamers with the dimer of trimers interface formed by the Nterminal α-helical domain (34, 35) . The observation that a Strep-tag placed at the Nterminus of NeuO was not accessible for purification might be an indication, that also in NeuO the N-terminal domain is involved in dimerization of NeuO trimers.
Recently, several genes encoding sialic acid specific O-acetyltransferases have been cloned by us and others: (i) oatC responsible for Oacetylation of the α2,9-linked polySia capsule of N. meningitidis of serogroup C (55) With the notable exception of OatC, which shares no sequence similarity to any known protein in the data base, all other sialic acid specific Oacetyltransferases were found to contain hexapeptide repeat sequences, indicating that these proteins are all members of the LβH family. However, the NeuD proteins might form a separate branch within the family, since amino acid sequence alignments revealed the lack of a potential catalytic histidine which might be substituted by a lysine residue (56) .
Although NeuO shares the typical features of the LβH family, the present study revealed a unique regulatory mechanism based on changes in VNTR-encoded N-terminal protein extensions. The neuO gene is characterized by the presence of a variable number of heptanucleotide repeats within the coding region (16 Because k cat /K m may be considered as a measure of the apparent first-order rate constant for enzyme-substrate interaction and reflects the affinity between enzyme and substrate to form a complex, the results are consistent with the interpretation that the presence of heptad repeats leads to a change in enzyme conformation with the resultant increase in enzyme-donor substrate affinity and facilitation of the reaction rate.
As suggested by Deszo et al. (16) , heptad repeats may assemble into a triple coiled coil. In the hexameric NeuO complex, variation in the length of such a coil might gradually change the subunit arrangement and thereby the conformation of the catalytic sites formed at the subunit interfaces of each trimer. However, the complete arrangement of all six subunits and the structure of the heptad repeats will only unequivocally be solved by analyzing the crystal structure of the NeuO complex.
In vivo, direct analysis of NeuO activity is hampered by frequent oscillation between ON and OFF phase. However, comparison of 10 different OAc + K1 strains indicated that VNTR-encoded protein extensions affect NeuO activity also in vivo and highest activities were found in strains expressing neuO alleles with more than 21 heptanucleotide repeats (16) . The analysis of capsular polysaccharides from four individual OAc + K1 strains revealed different degrees of O-acetylation ranging from 5 to 85% (14, 15) . Remarkably, the lowest O-acetyl content and lowest activity were found in a strain without detectable phase-variation (14, 15) , indicating that in vivo, modulation of NeuO activity has an impact on the degree of capsule O-acetylation. Table I ) and the obtained k cat /K m values were plotted versus the number of heptanucleotide repeats. Fig. 3 . Determination of the minimal acceptor length. Purified NeuO+36 was incubated with colominic acid and [
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14 C]acetyl-CoA. The reaction mixture was separated by 25% PAGE and radioactively labeled products were visualized by autoradiography (lane 1). The shortest detectable sialic acid oligomer is marked by an arrow. For size determination, radioactively labeled sialic acid oligomers with DP 3-18 were used as a marker (lane 2). In vivo analysis of NeuO mutants. E. coli K1 strain A160 (Ø), which lacks endogenous neuO, was transformed with the empty vector pQE32 (mock), pQE32-based plasmids containing wild-type neuO lacking the VNTR region (wt), and the corresponding mutant variants H119A and W143A. Bacteria were analyzed for O-acetylated capsular polysaccharide by an ELISA using mAb 58-5 (black bars). K1 capsule expression was controlled using mAb 735 (grey bars), which recognizes both OAc + and OAc -forms of the K1-antigen. Negative controls were performed using BSA instead of primary antibody. 
TABLE 1
Kinetic parameters of NeuO variants with different numbers of heptad repeats. NeuO activity was measured in the spectrophotometric assay at pH 7.5 and 25°C. Donor kinetics were determined using 0.025-2 mM acetyl-CoA with colominic acid at 2 mg/ml. Acceptor kinetics were determined using 0.015-2 mg/ml colominic acid (corresponding to 0.05-6.85 mM sialic acid residues) with acetyl-CoA at 2 mM. The steady-state parameters, K m and k cat , were determined from initial velocity measurements from at least three independent experiments measured in triplicate and values are given as mean ± S.D. TABLE 2 Acceptor specificity of NeuO. Relative enzymatic activities of purified NeuO+0 and NeuO+36 were determined in the presence of different acceptor substrates. All acceptor substrates were used at a concentration of 6.85 mM of total sialic acids and the activity obtained for colominic acid was set to 100%. Values are mean ± S.D. from 2 independent experiments measured in triplicate.
